¼¼°èÀÇ ³×ºí¶óÀÌÀú ½ÃÀå
Nebulizers
»óǰÄÚµå : 1760976
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 182 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,068,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,204,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

³×ºí¶óÀÌÀú ¼¼°è ½ÃÀåÀº 2030³â±îÁö 18¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 13¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ³×ºí¶óÀÌÀú ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö CAGR 5.0%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 18¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ Á¦Æ®´Â CAGR 4.9%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á±îÁö 12¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¸Þ½Ã ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 5.7%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 3¾ï 5,360¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 7.6%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ³×ºí¶óÀÌÀú ½ÃÀåÀº 2024³â¿¡ 3¾ï 5,360¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2024³âºÎÅÍ 2030³â ºÐ¼® ±â°£ µ¿¾È CAGR 7.6%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 3¾ï 9,920¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 2.8%¿Í 4.7%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 2.9%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°è ³×ºí¶óÀÌÀú ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ Á¤¸®

³×ºí¶óÀÌÀú´Â ¹«¾ùÀ̸ç, ¿Ö È£Èí±â Ä¡·á¿¡ Áß¿äÇѰ¡?

³×ºí¶óÀÌÀú´Â ¾×ü »óÅÂÀÇ ¾à¹°À» ÈíÀÔ °¡´ÉÇÑ ¹Ì¼¼ÇÑ ¹Ì½ºÆ®·Î º¯È¯ÇÏ¿© Æó¿¡ Á÷Á¢ ¾à¹°À» Àü´ÞÇÏ´Â µ¥ »ç¿ëµÇ´Â ÀÇ·á±â±âÀÔ´Ï´Ù. õ½Ä, ¸¸¼ºÆó¼â¼ºÆóÁúȯ(COPD), ³¶Æ÷¼º¼¶À¯Áõ°ú °°Àº È£Èí±âÁúȯÀÇ Ä¡·á¿¡ ÇʼöÀûÀÔ´Ï´Ù. ³×ºí¶óÀÌÀú´Â ÈíÀԱ⸦ »ç¿ëÇϱ⠾î·Á¿î ȯÀÚ, ƯÈ÷ ¾î¸°À̳ª ³ëÀÎ, ÁßÁõ È£Èí±âÁúȯÀ» ¾Î°í Àִ ȯÀڵ鿡°Ô º¸´Ù È¿°úÀûÀÎ Àü´Þ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. È£Èí±âÁúȯÀÌ Á¡Á¡ ´õ ³Î¸® ÆÛÁö°í ÀÖ´Â °¡¿îµ¥, ³×ºí¶óÀÌÀú´Â Àü ¼¼°è ¼ö¹é¸¸ ¸íÀÇ È¯Àڵ鿡°Ô ¾Èµµ°¨À» ÁÖ°í »îÀÇ ÁúÀ» Çâ»ó½ÃŰ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.

È£Èí±â Ä¡·á¸¦ °³¼±Çϱâ À§ÇØ ³×ºí¶óÀÌÀú´Â ¾î¶»°Ô ÁøÈ­Çϰí Àִ°¡?

³×ºí¶óÀÌÀú ½ÃÀåÀº ±â¼úÀÇ ¹ßÀü°ú ÇÔ²² ÁøÈ­Çϰí ÀÖÀ¸¸ç, µð¹ÙÀ̽º¸¦ º¸´Ù ÈÞ´ëÇϱ⠽±°í, È¿À²ÀûÀ̸ç, »ç¿ëÇϱ⠽±µµ·Ï ¹ßÀüÇϰí ÀÖ½À´Ï´Ù. ±âÁ¸ÀÇ Á¦Æ®½Ä ³×ºí¶óÀÌÀú´Â È¿°úÀûÀ̱ä ÇÏÁö¸¸ ºÎÇǰ¡ Å©°í ¼ÒÀ½ÀÌ ÄǽÀ´Ï´Ù. ¸Þ½Ã ³×ºí¶óÀÌÀú¿Í °°Àº »õ·Î¿î ¸ðµ¨Àº ´õ Á¶¿ëÇϰí ÈÞ´ë °¡´ÉÇÑ ¿É¼ÇÀ» Á¦°øÇÏ¿© »ç¿ëÀÚÀÇ ÆíÀǼºÀ» ³ô¿´½À´Ï´Ù. ÀÌ·¯ÇÑ Çõ½ÅÀº ¸¸¼º È£Èí±âÁúȯÀ» °ü¸®Çϴ ȯÀÚ µî ÀæÀº Åõ¾àÀÌ ÇÊ¿äÇÑ È¯Àڵ鿡°Ô ƯÈ÷ Áß¿äÇÕ´Ï´Ù. ¶ÇÇÑ, ÀçÅÃÀÇ·á¿¡¼­µµ ¹èÅ͸®·Î ÀÛµ¿ÇÏ´Â ¼ÒÇü ³×ºí¶óÀÌÀú¸¦ »ç¿ëÇÏ¸é º´¿ø ¹æ¹®ÀÇ Çʿ伺À» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, º¹¿ë·® ¹× º¹¾à ¼øÀÀµµ¸¦ ¸ð´ÏÅ͸µÇÏ´Â ½º¸¶Æ® ³×ºí¶óÀÌÀú°¡ º¸±ÞµÊ¿¡ µû¶ó ÀÇ·á ¼­ºñ½º Á¦°øÀڴ ȯÀÚÀÇ º¹¾à ¼øÀÀµµ¸¦ º¸´Ù È¿°úÀûÀ¸·Î ÃßÀûÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

³×ºí¶óÀÌÀú ½ÃÀåÀ» Çü¼ºÇϰí ÀÖ´Â Æ®·»µå´Â?

¿©·¯ °¡Áö ¿äÀÎÀÌ ¼¼°è ³×ºí¶óÀÌÀú ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖÀ¸¸ç, ±× Áß È£Èí±âÁúȯÀÇ À¯º´·ü Áõ°¡°¡ Áß¿äÇÑ ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ´ë±â¿À¿°°ú Èí¿¬ÀÇ Áõ°¡, °í·ÉÈ­°¡ È£Èí±âÁúȯÀÇ ±ÞÁõ¿¡ ±â¿©Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ³×ºí¶óÀÌÀú¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶Ç ´Ù¸¥ Áß¿äÇÑ Ãß¼¼´Â ƯÈ÷ ¸¸¼ºÁúȯ °ü¸®ÀÇ ÆíÀǼº ¶§¹®¿¡ ÈÞ´ë¿ë ¹× °¡Á¤¿ë ±â±â¿¡ ´ëÇÑ ¼±È£µµ°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, COVID-19ÀÇ ´ëÀ¯Ç൵ ³×ºí¶óÀÌÀú¿¡ ´ëÇÑ ¼ö¿ä¸¦ °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. ¹ÙÀÌ·¯½º °ü·Ã ÇÕº´ÁõÀ» Ä¡·áÇϱâ À§ÇØ È£Èí±â Áö¿øÀÌ ÇʼöÀûÀÌ µÇ¾ú±â ¶§¹®ÀÔ´Ï´Ù. ¶ÇÇÑ, ¿ø°ÝÀÇ·á°¡ ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖÀ¸¸ç, ȯÀÚµéÀº ¿ø°Ý ¸ð´ÏÅ͸µ ¹× °¡»ó Áø·á¸¦ À§ÇØ µðÁöÅÐ °Ç°­ Ç÷§Æû°ú ÅëÇÕÇÒ ¼ö ÀÖ´Â ±â±â¸¦ ¿øÇϰí ÀÖ½À´Ï´Ù.

³×ºí¶óÀÌÀú ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº?

³×ºí¶óÀÌÀú ½ÃÀåÀÇ ¼ºÀåÀº È£Èí±âÁúȯÀÇ ¹ß»ý·ü Áõ°¡, Àα¸ °í·ÉÈ­, ÀÇ·á±â¼úÀÇ ¹ßÀü µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ƯÈ÷ ¿À¿°µµ°¡ ³ôÀº µµ½Ã Áö¿ª¿¡¼­ õ½Ä ¹× COPD ȯÀÚ ¼ö°¡ Áõ°¡Çϸ鼭 ³×ºí¶óÀÌÀú ¼ö¿ä È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. È£Èí±âÁúȯ¿¡ Ãë¾àÇÑ °í·ÉÈ­ »çȸ´Â °í·É ȯÀÚ°¡ »ç¿ëÇϱ⠽¬¿î È£Èí º¸Á¶ ÀåÄ¡¸¦ ÇÊ¿ä·Î ÇÏ´Â °æ¿ì°¡ ¸¹±â ¶§¹®¿¡ ½ÃÀå ¼ºÀåÀ» ´õ¿í °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. ¸Þ½Ã ³×ºí¶óÀÌÀú ¹× ÈÞ´ë¿ë ¸ðµ¨ °³¹ß°ú °°Àº ³×ºí¶óÀÌÀú ¼³°èÀÇ ±â¼úÀû Áøº¸µµ äÅ÷üÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, COVID-19 ÆÒµ¥¹ÍÀ¸·Î ÀÎÇØ È®´ëµÈ ÀçÅÃÀÇ·á·ÎÀÇ ÀüȯÀº ÀçÅà ȣÈí±â Ä¡·á¿¡ ´ëÇÑ ³×ºí¶óÀÌÀú »ç¿ëÀ» Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù.

ºÎ¹®

À¯Çü(Á¦Æ®, ¸Þ½Ã, ÃÊÀ½ÆÄ), ÃÖÁ¾»ç¿ë(º´¿ø¡¤Å¬¸®´Ð, ±¸±Þ ¼¾ÅÍ, ÀçÅà ÇコÄɾî)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê(ÃÑ 13°³»ç)

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå°ú °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM ¹× ¾÷°è °íÀ¯ÀÇ SLMÀ» Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Nebulizers Market to Reach US$1.8 Billion by 2030

The global market for Nebulizers estimated at US$1.3 Billion in the year 2024, is expected to reach US$1.8 Billion by 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Jet, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Mesh segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$353.6 Million While China is Forecast to Grow at 7.6% CAGR

The Nebulizers market in the U.S. is estimated at US$353.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$399.2 Million by the year 2030 trailing a CAGR of 7.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.8% and 4.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Global Nebulizers Market - Key Trends & Drivers Summarized

What Are Nebulizers, and Why Are They Important in Respiratory Care?

Nebulizers are medical devices used to deliver medication directly to the lungs by converting liquid medicine into a fine mist that can be inhaled. These devices are essential in treating respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Nebulizers offer a more effective delivery method for patients who may struggle with inhalers, especially young children, the elderly, and those with severe respiratory issues. As respiratory diseases become more prevalent, nebulizers are critical in providing relief and improving the quality of life for millions of patients worldwide.

How Are Nebulizers Evolving to Improve Respiratory Treatment?

The nebulizer market is evolving with advancements in technology, making devices more portable, efficient, and user-friendly. Traditional jet nebulizers, while effective, have been bulky and loud. Newer models, such as mesh nebulizers, offer quieter and more portable options, enhancing convenience for users. These innovations are especially important for patients requiring frequent medication delivery, such as those managing chronic respiratory conditions. Home healthcare is also benefiting from these advancements, as patients can now use compact, battery-operated nebulizers, reducing the need for hospital visits. Additionally, smart nebulizers that monitor dosage and adherence are becoming more popular, allowing healthcare providers to track patient compliance more effectively.

What Trends Are Shaping the Nebulizer Market?

Several trends are influencing the global nebulizer market, with the increasing prevalence of respiratory diseases being a key factor. The rise in air pollution, smoking, and the aging population is contributing to a surge in respiratory illnesses, thereby driving demand for nebulizers. Another significant trend is the growing preference for portable and home-use devices, particularly due to the convenience they offer for chronic disease management. The COVID-19 pandemic has also accelerated the demand for nebulizers, as respiratory support became essential in treating virus-related complications. Moreover, telemedicine is influencing the market, as patients look for devices that can be integrated with digital health platforms for remote monitoring and virtual consultations.

What Is Driving the Growth of the Nebulizer Market?

The growth in the nebulizer market is driven by several factors, including the increasing incidence of respiratory diseases, the aging population, and advancements in medical technology. Rising cases of asthma and COPD, particularly in urban areas with high pollution levels, are contributing to the growing demand for nebulizers. The aging population, which is more prone to respiratory issues, further accelerates market growth, as elderly patients often require easy-to-use respiratory support devices. Technological advancements in nebulizer design, such as the development of mesh nebulizers and portable models, are also boosting adoption rates. Additionally, the shift towards home-based healthcare, amplified by the COVID-19 pandemic, has increased the use of nebulizers for at-home respiratory treatment.

SCOPE OF STUDY:

The report analyzes the Nebulizers market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Jet, Mesh, Ultrasonic); End-Use (Hospitals & Clinics, Emergency Centers, Home Healthcare)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 13 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â